Xencor

1 Follower

About

Xencor develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer.

Allen Yang
SVP, Chief Medical Officer
Celia Eckert
VP, General Counsel & Corporate Secretary
Eric P. Kowack
VP, Program Leadership & Strategic Alliances
Jeremy Grunstein
VP, Business Development
John J. Kuch
SVP & CFO
John R. Desjarlais
SVP Research & Chief Scientific Officer
Julie Casciani
VP, Human Resources
Kirk Rosemark
VP, Regulatory Affairs and Quality Assurance

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.